INIFY Laboratories AB Stock

Equities

INIFY

SE0017486103

Advanced Medical Equipment & Technology

Market Closed - Oslo Bors 10:45:00 2024-04-26 am EDT 5-day change 1st Jan Change
9.5 NOK +4.97% Intraday chart for INIFY Laboratories AB 0.00% -23.39%
Dynamic Chart
1 day+4.97%
Current month+2.15%
1 month+2.15%
3 months-26.36%
6 months-24.00%
Current year-23.39%
More quotes
1 week
8.80
Extreme 8.8
10.50
1 month
8.80
Extreme 8.8
10.90
Current year
8.80
Extreme 8.8
13.60
1 year
7.58
Extreme 7.58
17.00
3 years
4.02
Extreme 4.0165
17.00
5 years
4.02
Extreme 4.0165
17.00
10 years
4.02
Extreme 4.0165
17.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 49 21-11-09
Director of Finance/CFO 52 21-12-31
Chief Tech/Sci/R&D Officer 65 21-12-31
Members of the board TitleAgeSince
Chairman 62 21-11-09
Director/Board Member 71 22-04-30
Director/Board Member 69 21-11-09
More insiders
INIFY Laboratories AB is a Sweden-based medical research company that provides cancer diagnostics through laboratory services within pathology. The Company uses a fully digital, standardized and Artificial Intelligence (AI)- supported workflow to optimize quality and response times, initially within prostate. The service includes the whole chain of sample handling: from logistics, to sample preparation, to reporting by a pathologist from either Inify Laboratories or the customer’s organization. INIFY Laboratories' laboratory in Solna, Sweden is intended to provide two types of analyses of prostate Biopsy Specimens to clients: Full pathology Report signed by an INIFY subspecialized pathologist and Whole Slide Images (WSI) generation and result of Pathology Decision Support Tool (PDST) analysis only. The Company origins from ContextVision.
Calendar
More about the company